These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7530243)

  • 1. Are all carbapenems created equal?
    Iaconis JP; Nadler HL; Pitkin DH; Sheikh W
    J Antimicrob Chemother; 1994 Sep; 34(3):443-4. PubMed ID: 7530243
    [No Abstract]   [Full Text] [Related]  

  • 2. Are all carbapenems created equal?
    Baxter IA; Lambert PA
    J Antimicrob Chemother; 1995 May; 35(5):708-9. PubMed ID: 7592187
    [No Abstract]   [Full Text] [Related]  

  • 3. Are all carbapenems created equal?
    Simpson IN; Hunter R; Govan JR
    J Antimicrob Chemother; 1995 May; 35(5):707-8. PubMed ID: 7592186
    [No Abstract]   [Full Text] [Related]  

  • 4. Do all Pseudomonas cepacia produce carbapenemases?
    Simpson IN; Hunter R; Govan JR; Nelson JW
    J Antimicrob Chemother; 1993 Aug; 32(2):339-41. PubMed ID: 7693644
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients.
    Traczewski MM; Brown SD
    Antimicrob Agents Chemother; 2006 Feb; 50(2):819-21. PubMed ID: 16436756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and partial purification of a carbapenem-hydrolysing metallo-beta-lactamase from Pseudomonas cepacia.
    Baxter IA; Lambert PA
    FEMS Microbiol Lett; 1994 Oct; 122(3):251-6. PubMed ID: 7527361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Klebsiellapneumoniae isolates possessing KPC beta-lactamase in Israel, Puerto Rico, Colombia and Greece.
    Hawser SP; Bouchillon SK; Hoban DJ; Hackel M; Johnson JL; Badal RE
    Int J Antimicrob Agents; 2009 Oct; 34(4):384-5. PubMed ID: 19560904
    [No Abstract]   [Full Text] [Related]  

  • 8. Production of a plasmid-encoded OXA-72 β-lactamase associated with resistance to carbapenems in a clinical isolate Acinetobacter junii.
    Fernández-Cuenca F; Rodríguez-Martínez JM; Gómez-Sánchez MA; de Alba PD; Infante-Martínez V; Pascual A
    Int J Antimicrob Agents; 2012 Jan; 39(1):93-4. PubMed ID: 21982835
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases.
    Moczygemba LR; Frei CR; Burgess DS
    Clin Ther; 2004 Nov; 26(11):1800-7. PubMed ID: 15639692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro killing of carbapenems and aztreonam against Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.
    Panagiotakopoulou A; Daikos GL; Miriagou V; Loli A; Tzelepi E; Tzouvelekis LS
    Int J Antimicrob Agents; 2007 Mar; 29(3):360-2. PubMed ID: 17223016
    [No Abstract]   [Full Text] [Related]  

  • 11. Carbapenem-heteroresistance among isolates of the Enterobacter cloacae complex: is it a real concern?
    da Silva AEB; Martins AF; Nodari CS; Magagnin CM; Barth AL
    Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):185-186. PubMed ID: 29170902
    [No Abstract]   [Full Text] [Related]  

  • 12. SME-2-producing Serratia marcescens isolate from Switzerland.
    Poirel L; Wenger A; Bille J; Bernabeu S; Naas T; Nordmann P
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2282-3. PubMed ID: 17420208
    [No Abstract]   [Full Text] [Related]  

  • 13. First report of the carbapenem-resistant Pseudomonas aeruginosa producing IMP-7 metallo-beta-lactamase in Slovakia.
    Ohlasova D; Kmet V; Niks M
    Int J Antimicrob Agents; 2007 Oct; 30(4):370-1. PubMed ID: 17709230
    [No Abstract]   [Full Text] [Related]  

  • 14. Outbreak in Croatia caused by a new carbapenem-resistant clone of Acinetobacter baumannii producing OXA-72 carbapenemase.
    Goic-Barisic I; Towner KJ; Kovacic A; Sisko-Kraljevic K; Tonkic M; Novak A; Punda-Polic V
    J Hosp Infect; 2011 Apr; 77(4):368-9. PubMed ID: 21316806
    [No Abstract]   [Full Text] [Related]  

  • 15. IMP-1 metallo-beta-lactamase-producing Pseudomonas aeruginosa in a university hospital in the People's Republic of China.
    Wang CX; Mi ZH
    J Antimicrob Chemother; 2004 Dec; 54(6):1159-60. PubMed ID: 15537691
    [No Abstract]   [Full Text] [Related]  

  • 16. Occurrence of an SME-2-producing Serratia marcescens isolate in Canada.
    Carrër A; Poirel L; Pitout JD; Church D; Nordmann P
    Int J Antimicrob Agents; 2008 Feb; 31(2):181-2. PubMed ID: 18083009
    [No Abstract]   [Full Text] [Related]  

  • 17. WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases.
    Mushtaq S; Vickers A; Woodford N; Livermore DM
    J Antimicrob Chemother; 2017 Jun; 72(6):1688-1695. PubMed ID: 28333319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman.
    Dortet L; Poirel L; Al Yaqoubi F; Nordmann P
    Clin Microbiol Infect; 2012 May; 18(5):E144-8. PubMed ID: 22404169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Active surveillance of rectal colonization by carbapenemase-producing Enterobacteriaceae in hospitalized patients at the critical unit of private hospital in Santiago, Chile].
    Hervé B; Salas A; Corvalán V; Munizaga R
    Rev Chilena Infectol; 2015 Apr; 32(2):244-5. PubMed ID: 26065463
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of phenotypic tests for detecting BKC-1-producing Enterobacteriaceae isolates.
    Martins WM; Cordeiro-Moura JR; Ramos AC; Fehlberg LC; Nicoletti AG; Gales AC
    Diagn Microbiol Infect Dis; 2016 Mar; 84(3):246-8. PubMed ID: 26744087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.